Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials
John R Ingram(Cardiff University), Alexa B. Kimball(Beth Israel Deaconess Medical Center), Łukasz Matusiak(Wrocław University of Science and Technology), Ivette Alarcón(Novartis (Switzerland)), Angela Llobet Martinez(Novartis (Switzerland)), Jacek C. Szepietowski(Wroclaw Medical University), Magdalena B. Wozniak(Centre international de recherche sur le cancer), Christelle C Pieterse, Christine-Elke Ortmann(Novartis (Switzerland)), Georgios Kokolakis(Humboldt-Universität zu Berlin), D. Ioannides(Hospital Venereal and Skin Diseases Thessaloniki), Shoba Ravichandran(Novartis (United States)), Maryam Shayesteh Alam(Barrie Urology Group)
Cited by 2
Related Papers
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
|Journal of the European Academy of Dermatology and Venereology|2015|1.1k
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
|Journal of Investigative Dermatology|2014|954
Clinical Classification of Itch: a Position Paper of the International Forum for the Study of Itch
|Acta Dermato Venereologica|2007|748